Donnelley Financial Solutions Inc

Simply press star followed by the number one on your telephone keypad. And if you would like to withdraw your question, press the star one again. I would now like to turn the call over to Mike Tsao, Head of Investor Relations. Please go ahead.

Thank you. Good morning, everyone, and thank you for joining Donnelly Financial Solutions' third quarter 2025 results conference call. This morning, we released our earnings report. including a set of supplemental trending schedules of historical results, copies of which can be found in the Investors section of our website at DFINSolutions.com. During this call, we'll refer to forward-looking statements that are subject to risks and uncertainties. For a complete discussion, please refer to the cautionary statements included in our earnings release and further details in our most recent annual report on Form 10-K quarterly report on Form 10Q and other filings with the SEC. Further, we will discuss certain non-GAAP financial information, such as adjusted EBITDA and adjusted EBITDA margin. We believe the presentation of non-GAAP financial information provides you with useful supplementary information concerning the company's ongoing operations and is an appropriate way for you to evaluate the company's performance. They are, however, provided for informational purposes only. Please refer to the earnings release and related tables for GAAP financial information and reconciliations of GAAP to non-GAAP financial information. I am joined this morning by Dan Lieb, Dave Gardella, and other members of management. I will now turn the call over to Dan.

Thank you, Mike, and good morning, everyone. Our third quarter results offered further validation of our strategy, including the continued shift toward a favorable sales mix driven by double-digit growth in our SaaS offerings, strong year-over-year growth in adjusted EBITDA, and adjusted EBITDA margin expansion. In addition, we continued to make great progress in modernizing and expanding the adoption of our offerings in the marketplace, highlighted by the launch of our new venue virtual data room product. Against the backdrop of an improving but still soft capital markets transactional environment, which resulted in an 8% reduction in our event-driven transactional revenue, we delivered solid results, which once again demonstrated the resiliency of our operating model across various market conditions and the sustainability of our performance as our business mix continues to transform. Specific to our third quarter performance, I am pleased with the continued strong demand for our software offerings, where we delivered year-over-year net sales growth of 10.3%, an improvement compared to the growth rate we achieved in the first half of the year. Software solution sales represented approximately 52% of total sales in the quarter, a positive proof point of our transformation into a software-centric company. On a trailing four-quarter basis, software solution sales reached approximately $350 million. growing 8.5% from the third quarter 2024 trailing four quarters and accounted for 46.5% of trailing four quarter sales, an increase of approximately 640 basis points from the third quarter 2024 trailing four quarter sales. This continued positive mix shift positions us well to achieve our long-term target of deriving approximately 60% of total sales from software solutions by 2028. A major driver of the third quarter software growth was the performance of our recurring compliance software products, Active Disclosure and ArcSuite, which posted approximately 16% sales growth in aggregate, marking the third consecutive quarter of double-digit sales growth across these two products. The growth in our recurring compliance software offerings is led by Active Disclosure, which delivered third quarter net sales growth of approximately 26%, an acceleration in growth compared to recent trend. We are encouraged by the continued growth in active disclosure subscription service packages. In addition, as I discussed previously, we are serving additional use cases via a hybrid model that combines our software solution with an unmatched service offering. Within this context, active disclosure has been increasingly chosen by our clients for their IPO registration and proxy statement needs, which historically were managed in a traditional model. In the third quarter, we saw higher active disclosure sales associated with IPO registrations being completed on the platform compared to last year's third quarter. In the case of ArcSuite, the growth rate in the third quarter, approximately 10%, was more modest than the past few quarters as we overlapped the benefit associated with the tailored shareholder report solution, which was introduced in July of 2024. As I commented previously, we expect the growth profile of ArcSuite to be more modest during periods outside of regulatory changes, while over the longer term still exhibiting the double-digit growth we have delivered historically, based in part on a dynamic and evolving regulatory environment. For the fourth quarter, on a year-over-year basis, in addition to overlapping the TSR uplift, We will also overlap a contract renewal with a strategic client during last year's fourth quarter that produced favorable economics since the renewal. These factors combine to create a tough comparison versus the fourth quarter of last year when ArcSuite grew 23% year over year. I am encouraged by the continued adoption of ArcSuite among investment company clients as we build on the sales momentum and positive market response since launching our TSR solutions. As it relates to venue, we delivered improved year-over-year sales performance in the third quarter, increasing by approximately 3% compared to the third quarter of last year. We remain encouraged by venues' performance, which benefits from stable demand from both announced and unannounced deals across public and private companies alike. To further solidify venues' market position as a leading virtual data room for M&A due diligence, we launched a new version of Venu during the third quarter following a comprehensive rebuild. The redesigned Venu delivers a highly intuitive user experience, empowers clients to manage complex transactions more efficiently, streamlines collaboration within deal teams, and safeguards sensitive information throughout the deal's life cycle. Following the rollout, we have received very positive client feedback. Venu's modern architecture positions us well to efficiently add further capabilities as needed. We expect the new product launch will strengthen Venu as the data room of choice for corporate transactions. In addition to introducing new Venu, which serves our capital markets clients, during the third quarter, we released for broad adoption ArcFlex, the newest module within ArcSuite, designed specifically to meet the needs of investment companies focused on alternative investments. ArcFlex is a purpose-built financial and regulatory offering tailored for a wide range of private investment institutions, including hedge funds, private equity, and business development companies. By leveraging the foundational capabilities within the DFIN platform, ArcFlex builds on existing services to provide enhanced solutions customized for private fund clients. Coupled with DFIN's deep domain and service expertise, ArcFlex is well positioned as the leading end-to-end financial and regulatory reporting solution serving the growing private funds market. New Venue and ArcFlex are the latest in a series of new software introductions made possible by our focused investments to accelerate the modernization, innovation, and growth of our software portfolio. Over the past several years, these investments have enabled us to launch or modernize a majority of our software products. Our investments have enabled us to increase development velocity, bring new solutions to market more efficiently by leveraging the platform capabilities of our single compliance platform, and empower our clients to adapt quickly to an evolving regulatory environment, all while incorporating the most modern technology. Before turning the call over to Dave, I'd like to comment on the U.S. government shutdown and the related impact on our outlook for capital markets deal activity. Since the shutdown began on October 1st, the SEC's Division of Corporation Finance has been unable to review or accelerate registration statements, issue comment letters, or provide interpretive guidance. As a result, the SEC's ability to declare registration statements effective has been curtailed, impacting IPO activity as well as other capital markets transactions so far in the fourth quarter. While some transactions, including select IPO pricing, are taking place within a limited window without SEC comment, most of the planned transactional activity has been paused. Overall, the shutdown has delayed the positive momentum in capital markets deal activity over the last two quarters. Based on what we experienced during the previous government shutdown, this shutdown represents a shift in the timing of when transactions complete, as most deals that were paused during the previous shutdown were reactivated when the SEC reopened. While the duration of the shutdown remains uncertain, we continue to support our clients in preparing transactions so they remain ready to move quickly when regulatory operations at the SEC resume. Deep and strong client relationships and market leadership position us well to capture the latent demand when activity level normalizes. Before I share a few closing remarks, I would like to turn the call over to Dave to provide more details on our third quarter results and our outlook for the fourth quarter. Dave?

Thanks, Dan, and good morning everyone. Before I discuss our third quarter operating performance, I'd like to recap one housekeeping item. As detailed in our press release issued on October 23rd, during the third quarter, we successfully completed the termination of our primary defined benefit pension plan, which had been frozen and closed since 2011. As part of this transaction, We made a $12.5 million cash contribution in the third quarter to fully fund the plan, which was recorded as a use of cash within the operating activity section of the statement of cash flows and settled the plan obligations through a combination of lump sum payments to certain plan participants and the purchase of a group annuity contract from a third party insurer. In addition, As a result of the plan settlement, we remeasured the plan's assets and obligations and recognized a non-cash pre-tax settlement charge of $82.8 million or $60.3 million on an after-tax basis, resulting in a negative EPS impact of $2.20 per diluted share due to the recognition of unrealized accumulated plan losses previously reported within accumulated other comprehensive loss on the balance sheet. Finally, the settlement of the plan resulted in the removal of approximately $10 million of net liability from our balance sheet comprised of approximately $200 million of plan obligations and approximately $190 million of plan assets. We are pleased with this outcome which will further enhance our financial flexibility and reduce future administrative and financial volatility associated with the legacy pension plan. Now turning to our third quarter operating performance. As Dan noted, we delivered strong results within the backdrop of an improved operating environment highlighted by an acceleration in software solutions growth and year-over-year increases in adjusted EBITDA and adjusted EBITDA margin. We posted approximately 10% growth in our software solutions net sales, including approximately 16% sales growth in our recurring compliance software products, all while continuing to drive operating efficiencies and expanding adjusted EBITDA margin to 28.2%. On a consolidated basis, total net sales for the third quarter of 2025 were $175.3 million, a decrease of $4.2 million, or 2.3% from the third quarter of 2024. Third quarter net sales were at the high end of our guidance range. aided by capital markets transactional revenue, which exceeded our expectation, though we're modestly down compared to last year's third quarter. The decrease in year-over-year consolidated net sales was driven by lower volume in our compliance and communications management segments, which declined $12.7 million in aggregate, with compliance revenue across the capital markets and investment companies' businesses accounting for $8.3 million of the decline. The reduction in compliance revenue was mostly reflected in lower print and distribution volume related to both the ongoing decline in this area consistent with recent trend, as well as the timing impact of certain investment companies print volume that shifted from the third quarter into the fourth quarter this year. In addition, Total event-driven transactional revenue declined by $4.4 million year over year, primarily a result of the lower volume for foreign issuer transactions on U.S. exchanges, partially offset by stronger U.S. IPO volume. These declines were partially offset by growth in software solutions net sales, which increased $8.5 million, or 10.3%, compared to the third quarter of last year. Third quarter adjusted non-GAAP gross margin was 62.7%, approximately 100 basis points higher than the third quarter of 2024, primarily driven by higher software solutions net sales, the impact of cost control initiatives, and price uplifts partially offset by lower capital markets transactional volume. Adjusted non-GAAP SG&A expense in the quarter was $60.5 million, a $7.1 million decrease from the third quarter of 2024. As a percentage of net sales, adjusted non-GAAP SG&A was 34.5%, a decrease of approximately 320 basis points from the third quarter of 2024. The decrease in adjusted non-GAAP SG&A expense was primarily driven by the impact of cost control initiatives, a reduction in selling expense related to lower sales in certain areas, and lower bad debt expense, which continued to normalize in the third quarter, partially offset by higher healthcare expense. Our third quarter adjusted EBITDA was $49.5 million. an increase of $6.3 million, or 14.6%, from the third quarter of 2024. Third quarter adjusted EBITDA margin was 28.2%, an increase of approximately 410 basis points from the third quarter of 2024, primarily driven by higher software solutions net sales, cost control initiatives, and lower selling expense as a result of the decrease in sales volume, partially offset by lower capital markets transactional volume and higher healthcare expense. Turning now to our third quarter segment results, net sales in our capital markets software solution segment were $59 million, an increase of $5.7 million, or 10.7% from the third quarter of last year, primarily driven by active disclosure, which was up $4.7 million year over year. During the third quarter, active disclosure sales grew approximately 26%, an acceleration of the stronger growth trend we experienced over the last three quarters, primarily driven by the continued adoption of active disclosure subscription service packages and the ongoing migration of certain activities historically performed on our traditional services platform. The migration to a hybrid model enables clients to leverage the combination of active disclosure and defense service model. Specific to the shift of traditional activities to active disclosure, during the quarter, we experienced an increase in the volume of IPO activity, taking advantage of the hybrid offering with clients using active disclosure for the drafting and filing of S-1 documents, resulting in higher usage of active disclosure for certain IPO transactions. We remain encouraged by active disclosure's solid foundation for future revenue growth, part of which will be influenced by the amount of event-driven transactional activity taking place on the platform. Net sales of venue increased approximately $1 million, or 3%, compared to the third quarter of last year when venue grew approximately 27% year over year. A resilient level of underlying activity taking place on the platform, coupled with our recent launch of new venue, creates a strong foundation for future sales growth. Adjusted EBITDA margin for the segment was 34.9%, an increase of approximately 1,010 basis points from the third quarter of 2024, primarily due to the increased sales, cost control initiatives, and lower bad debt expense. Net sales in our capital markets compliance and communications management segment were $57.2 million, a decrease of $6.3 million, or 9.9% from the third quarter of 2024, driven by lower transactional revenue, as well as a reduction in compliance volume, part of which was related to lower print and distribution sales consistent with recent trends. In the third quarter, we recorded $41.8 million of capital markets transactional revenue, which exceeded the high end of our expectations, yet was down $3.5 million from last year's third quarter. Following the second quarter, when we experienced sequential improvement in transactional revenue as the quarter progressed, the uptick in the level of capital markets deal activity, especially the market for new equity issuances, in the US strengthened in the third quarter with the number of regular way IPO transactions that raised over $100 million exceeding last year's levels. As such, we realized approximately 25% year-over-year increase in our transactional revenue related to US IPO activity. However, the improvement in US IPO activity was more than offset by the soft market for foreign issuance transactions and large public company M&A deals, which remained a headwind on a year-over-year basis and combined to more than offset the growth in IPO revenue. With the outlook for capital markets transactional environment is uncertain, in part due to the impact of the government shutdown, DFIN remains very well positioned to capture future demand for transactional related products and services when market activity resumes. Capital markets compliance revenue decreased by $2.8 million, or 15.4%, compared to the third quarter of 2024, driven primarily by lower volume of compliance work, including the related printing and distribution consistent with the trend from the first half of the year. In addition, we continue to experience lower market demand for certain event-driven filings, such as 8K and special proxies associated with corporate transactions. Adjusted EBITDA margin for the segment was 34.3%, an increase of approximately 260 basis points from the third quarter of 2024. The increase in adjusted EBITDA margin was primarily due to cost control initiatives, lower selling expense as a result of lower sales volume, and lower bad debt expense partially offset by lower sales volume. Net sales in our investment company's software solution segment were $31.7 million, an increase of $2.8 million, or 9.7%, versus the third quarter of 2024, driven by growth in subscription revenue. As expected, the growth rate in the third quarter was more modest compared to the levels we delivered in the last several quarters as we started to overlap the uplift in software revenue as a result of the tailored shareholder reports regulation, which became effective in July of last year. As Dan stated earlier, We expect a tough comparison against last year's fourth quarter as we overlap uplifts associated with both TSR and the strategic contract renewal, which benefited our performance last year. Adjusted EBITDA margin for the segment was 36.6%, an increase of approximately 580 basis points from the third quarter of 2024. The increase in adjusted EBITDA margin was primarily due to operating leverage on the increase in net sales, price uplifts, and cost control initiatives, partially offset by higher service-related costs associated with the tailored shareholder reports offering. Net sales in our investment companies compliance and communications management segment were $27.4 million, a decrease of $6.4 million, or 18.9% from the third quarter of 2024, primarily driven by lower print and distribution volume, which accounted for $4.1 million of the year-over-year decline and lower compliance revenue. Third quarter print and distribution revenue within this segment was impacted by the timing shift of certain volume related to tailored shareholder reports for the variable annuity market from the third quarter into the fourth quarter of this year, as well as the ongoing impact of lower page counts related to tailored shareholder reports for the mutual fund industry. Going forward, we expect a broader secular decline in the demand for printed products, which we expect in the range of 5% to 6% will continue to result in lower print and distribution revenue within this segment, in addition to any future regulatory change driven impacts. Adjusted EBITDA margin for the segment was 34.7%, approximately 450 basis points higher than the third quarter of 2024. The increase in adjusted EBITDA margin was primarily due to lower selling expense and cost control initiatives partially offset by the impact of lower sales volume. Non-GAAP unallocated corporate expenses were $11.8 million in the quarter, an increase of $2.6 million from the third quarter of 2024, primarily due to higher healthcare expense partially offset by cost control initiatives. As it relates to the increase in healthcare expense, The variance was driven by a single outsized claim, a portion of which is eligible for reimbursement through a stop loss insurance policy. The company received a $2.8 million reimbursement this week in accordance with that policy. And as such, we will record the $2.8 million recovery in our fourth quarter results. Free cash flow in the quarter was $59.2 million. $8.1 million lower than the third quarter of 2024. The year-over-year decline in free cash flow was primarily driven by unfavorable working capital and the one-time cash contribution related to the pension plan settlement, partially offset by lower cash tax payments, higher adjusted EBITDA, and lower capital expenditures. We ended the quarter with $154.7 million of total debt and $132 million of non-GAAP net debt, including $43 million drawn on our revolver. As of September 30th, 2025, our non-GAAP net leverage ratio was 0.6 times. Regarding capital deployment, we repurchased approximately 659,000 shares of common stock during the third quarter for $35.5 million at an average price of $53.79 per share. Year to date through September 30th, we've repurchased approximately 2.3 million shares for $111.6 million at an average price of $48.35 per share. As of September 30th, 2025, we had $114.5 million remaining on our current $150 million stock repurchase authorization. We continue to view organic investments to drive our transformation, share repurchases, and net debt reduction as key components of our capital deployment strategy and will remain disciplined in this area. As it relates to our outlook for the fourth quarter of 2025, we expect consolidated fourth quarter net sales in the range of $150 million to $160 million and adjusted EBITDA margin in the range of 22% to 24%, which at the midpoint represents an increase of approximately 300 basis points compared to last year's fourth quarter, where we posted adjusted EBITDA margin of approximately 20%. Our fourth quarter adjusted EBITDA guidance reflects the stop loss reimbursement of approximately $2.8 million received this week, as I noted earlier. In terms of our revenue guidance, the midpoint of $155 million implies a reduction of approximately 1% compared to the fourth quarter of last year, as lower print and distribution sales and lower capital markets transactional sales are expected to more than offset growth in software solutions. I'll also provide a bit more color on our assumptions for the capital markets transactional sales. Due to the impacts of the government shutdown and the resulting increase in uncertainty around timing of deal completions, our expectations for capital markets transactional revenue reflect a temporary softening relative to the recent trajectory. Our estimates assume capital markets transactional net sales in the range of $30 million to $40 million, which at the midpoint, is down approximately $2.7 million from last year's fourth quarter and represents a sequential decline of approximately $7 million from the third quarter of this year solely due to the government shutdown. This guidance assumes transactions that were approved before the shutdown will proceed in the normal course of business. As it relates to new transactions, In line with what we have seen thus far in October, we expect some deals, such as IPOs currently in the pipeline, to be completed during the fourth quarter based on guidance provided by the SEC, though we expect most in-process deals will be delayed. Conversely, our guidance assumes a continuation of the year-over-year growth trend we've seen in venue, driven by the new product release and further supported by an improvement in underlying market activity. With that, I'll now pass it back to Dan.

Thanks, Dave. The execution of our strategy continues to deliver positive results and further demonstrates DFIN's ability to perform well in varying market conditions. Our solid financial profile provides us with the foundation to continue to execute our strategic transformation. While the government shutdown has injected uncertainty into the capital market's transactional environment, the combination of our strong market position and deep domain expertise position deepened well to capitalize on the return to a more normalized level of activity. We are in the midst of preparing our 2026 operating plan and extending our long-range plan through 2030. In 2026, we expect to build on the positive momentum in growing our software solutions portfolio including accelerating the shift of our traditional compliance activities to SAS, continued operational transformation, and the execution of our strategy. Through the planning period, we expect continued progress in delivering higher value for our clients, our employees, and our shareholders. Consistent with past practice, we expect to provide an update on 2026 and our long-range projections in February. Before we open it up for Q&A, I'd like to thank the decent employees around the world. Now with that, operator, we're ready for questions.

Thank you for that. We will now begin the question and answer session. If you have dialed in and would like to ask a question, please press star 1 on your telephone keypad to raise your hand and join the queue. And if you would like to withdraw your question, simply press the star 1 again. If you are called upon to ask your question and listening via loudspeaker on your device, please pick up your handset and ensure that your phone is not on mute when asking a question. Again, please press star one to join the queue. And your first question comes from the line of Charles Strasser of CJS Securities. Please go ahead.

Hi, good morning. Morning. Um, maybe we can just pick up on the, uh, the government shutdown discussion. And, uh, you know, when you look at the, thank you for giving us the quantification in your guidance for Q4 for revenue, but, um, any, any, you know, metrics you can give us around the, um, the impact of margins in Q4.

Yeah, Charlie, I'll talk about that. I think, you know, we've contemplated the margin impact of the lower transactional revenue in our range, you know, as we talked about margins in the quarter range. We, you know, even at the midpoint at 23% for Q4, expect, you know, to be up about 300 basis points relative to what we delivered last year. And again, I think that's in line with the margin expansion we've seen so far this year. Obviously, that has a bit of a negative impact in Q4. But the piece that we have going the other way, right, we talked about the outsized healthcare, we're going to get a recovery on that. In Q4, we've actually already received the cash for that recovery. And so when you look at the 300 basis points of margin expansion, again, that's at the midpoint of our guidance, about half of that is driven by this healthcare recovery. And then I would say the other half just kind of in line with our ongoing margin expansion You know, as you saw in this quarter, to the extent that that capital markets transactional revenue comes in higher, you know, we would expect to outperform that just like we did in Q3. And that was a big driver. You know, that'll be the swing factor, I guess, in any quarter, but certainly as we face the government shutdown here in Q4.

Yeah, and then just to add, and maybe Craig can also provide some context to past shutdowns and impact, but the impact of the shutdown, as we said, is primarily in our capital markets transactions area. All of the compliance activities that run through the SEC continue during the shutdown other than those that are associated with transactions, but, you know, minimal impact to venue, and Craig can speak to both venue and then what we've seen from past shutdowns.

Yeah, Charlie, to build on Dave and Dan's comments, the SEC posted guidance that provides a path forward for companies seeking to IPO. So, unlike past shutdowns, the IPO market is frozen for most, but not all. It cannot, the SEC cannot declare a registration statement effective, but instead they've instructed companies to file a completed statement and wait 20 days. So there are companies that are pressing ahead. As we look at October, we have five listings that have completed. Four are traditional IPOs greater than 100 million. Two of those are DFIN deals. We've also completed one very large direct listing this month, which closed up 480% a DFIN deal. And then you look forward, according to Renaissance Capital, six companies intend to price in the next few weeks using the SEC's 20-day guidance. DFIN is working with five of those six. And then if you look at the total number of publicly companies on file, at the SEC to price, including a six that is a total of 13 with a $50 million or greater placeholder. These are publicly filed but not priced. A DFEN supported deal joined the list yesterday, Medline, could be the largest IPO of the year. And their public filing signals that despite the shutdown, the IPO market continues to move forward. DFEN share these 13 deals 69%. We have a robust pipeline of companies who follow confidentially, as well as an IPO pipeline of RFPs. So it is definitely impacted. It has slowed, hasn't completely stopped given the 20-day rule. And then to build on some of the M&A comments that Dan talked about, we're really fortunate at DFIN to have a business that delivers M&A support from deal ideation through the process to announce transactions that require public disclosure. With Venu, it's a really optimistic look, as Dan and Dave stated. Q3 results show progress. We're seeing increased activity in Venu, and we have a new product. Clients are loving it. Venu's architecture will provide us great leverage going forward. And we expect the product launch to strengthen venue as the data room of choice, and we look forward to those accomplishments in future quarters. But M&A in the traditional side is impacted. It is already a complex regulatory environment, and the government shutdown has exacerbated this. So we expect deals that were to close in Q4 to be pushed to 2026 due to regulatory bottleneck. While we know the government will open, we can't predict it, and we've been here before. These delayed transactions will get completed, but it likely could be 2026. It's going to take a beat for the market to catch up once the government opens, and then we're working against the holidays here in November and December. So it's going to open. The underlying activity is strong, and DFIN is at the ready.

Great. Thank you. Thank you for that. Shifting gears a little bit to the talk about SEC reporting frequency from quarterly to essentially semiannual, how are you thinking about that? And, you know, any, you know, knowledge you could share with us?

Yeah. Great question. So we're closely monitoring the developments related to the proposal to reduce the frequency of corporate reporting. At this time, many, many questions are outstanding. So will the proposal require more disclosure for a semiannual report than a current 10-Q? What will the XBRL tagging requirements be? Another option is for the SEC to continue to require quarterly earnings, 8Ks. These could be larger. And does it expand the 8K disclosure that would require XBRL tagging? We're also analyzing what happened in Europe. Companies here will be given a choice. Most European countries, companies, sorry, when given a choice, did not reduce the frequency of reporting. So we really don't know what the adoption rate will be here in the U.S. So given these unknown aspects, we're continuing to build models and to follow it. But I think the most important point to make is the vast majority of our 10Qs are on active disclosure, which operates as a subscription business with long-term contracts. So this subscription model insulates DFEN from most of the public change that would be associated with this. as the subscription is priced not on a per filing basis, but on a software delivery basis. So following it closely, we have some insulation to the impact.

Great. Thank you very much.

And your next question comes from the line of Pete Heckman of DA Davidson. Your line is now open.

Thank you. Hey, good morning, everyone. Wanted to follow up on this resurgence of SPAC IPOs that we've seen over the last, what, four to six quarters. When we think about DFIN's participation there, I guess, how much of DFIN not getting retained on some of these deals is the company's choice and worries about potentially those deals not getting done? and how much of it is just a more competitive, you know, set of competitors, kind of all on these lower-end IPOs.

Yep. DFEN is selected in our SPAC go-to-market, and as you're familiar with, the reasons why risk of liquidation, delisting, merger terminations, There is an increase in the quantity, and there is a few quality deals, and those are the ones that we play at. Our share in this increased market has declined, but it's declined because 58% of the year-to-date deals are nano microcap companies. 25% are trading below the $5 per share. 33% are international. Most of those have an international provider. And 50% of the SPACs have been public for over three years, so they're struggling to find a target. So we continue to be selective due to these reasons. We're aware of the activity levels and remain really diligent on reviewing the opportunities. We are participating in quality SPAC and de-SPAC deals with Tier 1 deal teams. And the issuers that use a competitor for a SPAC merger TAB, Mark McIntyre, And have completed it we're attacking those clients and winning their future 34 act reporting on active disclosure so contracted revenue to some of these companies when they get through we're able to upgrade them from the lower end providers.

Okay, that's helpful. And then just in terms of venue in October, I'm not sure if you can give us too much insight there. But, you know, just thinking about, you know, we have seen an uptick in larger M&A deals in the bank sector and some other sectors. I guess, are you seeing the benefit of that? And to the extent that there is a slowdown in government reviews that slow down M&A, the process of M&A towards closing? would you expect to see that October, November, you know, kind of, what do you think is the timing there? And then in prior shutdowns, I guess, how fast does the catch-up occur? Yeah. Yeah, Pete, it's... Go ahead, David. I'll start and then you can jump in. I think certainly the momentum that we saw in venue in Q3, you know, it's embedded in our guidance in Q4 as well. I think the underlying activity still remains and, you know, regardless of the shutdown and deals getting completed, it's one of the great things, and we've talked about this in the past, that, you know, if you look, describe the market as the number of completed deals you may get a very different answer than the activity that's going on, you know, underneath the waterline, so to speak. And we feel really good about how we're positioned with Venue, especially with the new product in the market and the acceptance that we're getting thus far. Go ahead, Craig.

To build on that, Dave, thank you. We're playing in the formal process of deals coming to market. So before they're announced, certainly before they close. So as Dave said, excited by that opportunity. We have pitches that are up, opportunity creation that is up. So all moving in the right direction as we see what you see. Given that we have this broad application serving both announced and unannounced, We have a lot of activity there, but certainly the government shutdown is worsening an already complex regulatory landscape. So I think you're probably referencing the antitrust. You have healthcare technology energy deals that are delayed. They already were delayed given the HSR Act updates, which has added time and complexity to the process. The government shutdown exacerbated this. So again, likely to see these deals that had anticipated to close, close later, potentially in 2026. So what we expect to see is a government that opens, it will take a while to get moving again. One of the things that's been eliminated during the shutdown is the Trump administration had been able to terminate the waiting period. But with the shutdown, they don't have the staff to do it. So we would anticipate a build. It likely will be in 2026. Okay.

All right. That's very helpful. I appreciate it.

Your next question comes from the line of Kyle Peterson of Needham. Your line is now open.

Hey, good morning, guys. Thanks for taking the questions. Let's start off, particularly in the tax rate this quarter, it looks like you guys had a pretty big kind of one-time benefit. Is that related to, you know, the pension plan settlement and everything like that, or were there any, like, discrete items or anything that that skewed the tax rate around this quarter that we should be mindful of?

Yeah, Kyle, I think, you know, we talked about the pre-tax pension charge of the, you know, just over $80 million, the post-tax at $60 million. So certainly the pension, the tax component of that weighed on the gap tax rate, I think. you know, in the non-GAAP tax rate, a little bit different story there where we exclude it, but, you know, some small dollars of adjustments there related to, you know, different tax legislation, et cetera, can impact that rate. Okay.

Okay. That's helpful. So even though it's, you guys settled the pension formally in the fourth quarter, it was a noise item in the third quarter.

Um, uh, so we, Kyle, just to be clear, that was, we, we settled in the third quarter.

Okay. Yeah. Sorry. You now sit in the fourth quarter at least, but yeah. Um, okay. That, um, all right. That is, is super helpful. Um, and then I wanted to kind of follow up on venue and I realized it's probably a little hard to answer, but, Is there any way you guys could maybe tease some or parse out some of the momentum that you guys are seeing in venue? If there's any way you guys could separate the benefits from the redesigned product versus activity potentially picking up, which one you... feel or whether it's qualitative feedback or or anything like that like what do you guys feel has been the bigger driver of uh you know the better performance and everything there and um you know how should we think or in past product refreshes like how long has it taken to get um you know more traction and and such that'd be helpful

Yeah, I'll start. And then, Craig, if you want to jump in, I think when you look at venue, obviously, we showed the growth this quarter. But if you take a longer-term view of venue, we grew in the mid-20% range last year. We were overlapping a quarter in Q3 that was right along those growth rates. So I would say sales execution has been the key component to driving the growth that we've seen. That team's done a really nice job in terms of, you know, as Craig talked about, generating new opportunities and converting those opportunities. With respect to the new product, you know, I would say it had a very, very modest impact in Q3. We would expect more of an impact in Q4. and then certainly the bulk of the impact of the new product to start to hit in 2026. So I think the impact of the new product, you know, the better days due to that product are on the horizon here for us, correct?

Yes, I will build on the horizon part, which is our results to date are based on execution The earlier results in the year were a function of Liberation Day, which sort of froze the market. Now we see that has absorbed, and the M&A opportunities are certainly increased. When we launched the new version of NU, it launched in the first weeks of October. These launch events continue today. So the prospective look is that what you're seeing is primarily a result of execution pre-launch. You know, certainly we have a product that we think is the most purpose-built based on decades of experience. Again, clients are loving it. We expect this new product launch is going to strengthen us as the data room provider of choice. It will be in future quarters. Our venue team is going to continue to deliver excellence, given the nature of venue. We're going to focus on what's got us here, sales execution, taking share, price, and then now we're supported by a great new product.

Okay. That's super helpful. And then if I could squeeze one last one in here. Are you guys thinking about capital allocation? At this point, you guys have kind of taken a lot of the uncertainty or volatility out of the pension liability at this point. Cash flow continues to improve. At least the market doesn't seem to be giving gas credit for at least like a strong pipeline. And whenever the shutdown gets resolved, we'll have a resurgence in activity, but like, I guess, like, how are you guys kind of thinking and kind of rank order and like uses of excess cashflow, um, you know, between buybacks and, you know, other, other uses, any, any color there I think would be, be helpful for everyone to call.

Yeah, sure. Thanks Kyle. So, uh, no, no change relative to, um, what we've been doing historically, you know, we've said, uh, often the number one priority is having the financial flexibility to execute the transformation and our strategy. Um, you know, to your point, we are, have quite a bunch or quite a bit of financial flexibility and capacity. Um, and yeah, we, you know, as, as evidenced in the last quarter, as evidenced back in April, um, we've been very aggressive in buybacks, uh, at the appropriate times. Um, And, you know, we think about priorities. It's the strategy. It's maintaining that financial flexibility, being opportunistic around share repurchases and disciplined. And then, you know, we're looking at ways of accelerating organic or inorganic investment in the business, but only to accelerate the strategy.

All right. Appreciate all the color and help. Thanks, guys.

Right. Thank you.

Again, if you would like to ask a question, please press star one to join the queue. We'll pause for just a moment to compile the Q&A roster. And there are no questions at this time. I will now turn the conference back over to Dan Lieb for closing remarks.

Great. Thank you, and thank you, everyone, for joining, and we'll look forward to speaking with you soon. Thanks.

Ladies and gentlemen, that concludes today's call. Thank you all for joining. You may now disconnect.